{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:53:57Z","timestamp":1793915637881,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40120-025-00750-w","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:42:10Z","timestamp":1746265330000},"page":"1093-1103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence and Prevalence of Juvenile Myasthenia Gravis in the United States Between 2010 and 2020: Analysis of Two Claims Databases"],"prefix":"10.1007","volume":"14","author":[{"given":"Jiachen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Nilius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pilipczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00efs","family":"Taranc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tennigkeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"750_CR1","unstructured":"National Institutes of Health. U.S. Department of Health and Human Services. Myasthenia Gravis (2020). NIH Publication No. 20-NS-7686. https:\/\/www.ninds.nih.gov\/sites\/default\/files\/migrate-documents\/myasthenia_gravis_e_march_2020_508c.pdf. Accessed Nov 2024"},{"key":"750_CR2","volume":"2011","author":"MF Finnis","year":"2011","unstructured":"Finnis MF, Jayawant S. Juvenile myasthenia gravis: a paediatric perspective. Autoimmune Dis. 2011;2011: 404101.","journal-title":"Autoimmune Dis"},{"key":"750_CR3","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1055\/s-0043-120334","volume":"02","author":"A Della Marina","year":"2018","unstructured":"Della Marina A, Schara U. Juvenile myasthenia gravis. Neurol Int Open. 2018;02:E6\u20139.","journal-title":"Neurol Int Open"},{"key":"750_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fneur.2020.00743","volume":"11","author":"K O'Connell","year":"2020","unstructured":"O\u2019Connell K, Ramdas S, Palace J. Management of juvenile myasthenia gravis. Front Neurol. 2020;11:743.","journal-title":"Front Neurol"},{"key":"750_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ejpn.2017.04.003","volume":"21","author":"TH Popperud","year":"2017","unstructured":"Popperud TH, Boldingh MI, Rasmussen M, Kerty E. Juvenile myasthenia gravis in Norway: clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort. Eur J Paediatr Neurol. 2017;21:707\u201314.","journal-title":"Eur J Paediatr Neurol"},{"key":"750_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000311012","volume":"35","author":"CH Lai","year":"2010","unstructured":"Lai CH, Tseng HF. Nationwide population-based epidemiological study of myasthenia gravis in Taiwan. Neuroepidemiology. 2010;35:66\u201371.","journal-title":"Neuroepidemiology"},{"key":"750_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.1468-1331.2012.03698.x","volume":"19","author":"M Gattellari","year":"2012","unstructured":"Gattellari M, Goumas C, Worthington JM. A national epidemiological study of Myasthenia Gravis in Australia. Eur J Neurol. 2012;19:1413\u201320.","journal-title":"Eur J Neurol"},{"key":"750_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/mus.24348","volume":"51","author":"B Mombaur","year":"2015","unstructured":"Mombaur B, Lesosky MR, Liebenberg L, Vreede H, Heckmann JM. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa. Muscle Nerve. 2015;51:533\u20137.","journal-title":"Muscle Nerve"},{"key":"750_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","volume":"99","author":"JR Parr","year":"2014","unstructured":"Parr JR, Andrew MJ, Finnis M, Beeson D, Vincent A, Jayawant S. How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia. Arch Dis Child. 2014;99:539\u201342.","journal-title":"Arch Dis Child"},{"key":"750_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ajo.2019.01.004","volume":"200","author":"SA Mansukhani","year":"2019","unstructured":"Mansukhani SA, Bothun ED, Diehl NN, Mohney BG. Incidence and ocular features of pediatric myasthenias. Am J Ophthalmol. 2019;200:242\u20139.","journal-title":"Am J Ophthalmol"},{"key":"750_CR11","volume":"5","author":"J Chen","year":"2020","unstructured":"Chen J, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study. Lancet Reg Health West Pac. 2020;5: 100063.","journal-title":"Lancet Reg Health West Pac"},{"key":"750_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261983","volume":"16","author":"IM Carey","year":"2021","unstructured":"Carey IM, et al. Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: a retrospective study using primary care data. PLoS ONE. 2021;16: e0261983.","journal-title":"PLoS ONE"},{"key":"750_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.nmd.2023.02.002","volume":"33","author":"A Mevius","year":"2023","unstructured":"Mevius A, et al. Epidemiology and treatment of myasthenia gravis: a retrospective study using a large insurance claims dataset in Germany. Neuromuscul Disord. 2023;33:324\u201333.","journal-title":"Neuromuscul Disord"},{"key":"750_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/mus.28006","volume":"69","author":"E Rodrigues","year":"2024","unstructured":"Rodrigues E, Umeh E, Uday A, Navaratnarajah N, Cole A, Moy K. Incidence and prevalence of myasthenia gravis in the United States: a claims-based analysis. Muscle Nerve. 2024;69:166\u201371.","journal-title":"Muscle Nerve"},{"key":"750_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s40272-024-00649-3","volume":"26","author":"S Ramdas","year":"2024","unstructured":"Ramdas S, Painho T, Vanegas MI, Famili DT, Lim MJ, Jungbluth H. Targeted treatments for myasthenia gravis in children and adolescents. Paediatr Drugs. 2024;26:719\u201340.","journal-title":"Paediatr Drugs"},{"key":"750_CR16","unstructured":"Strober, et al. Safety and effectiveness of nipocalimab in adolescent participants in the open label Phase 2\/3 Vibrance-MG clinical study\u00a0[presentation]. AANEM 2024."},{"issue":"2","key":"750_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.36469\/001c.87538","volume":"10","author":"O Baser","year":"2023","unstructured":"Baser O, Samayoa G, Yapar N, Baser E, Mete F. Use of open claims vs closed claims in health outcomes research. J Health Econ Outcomes Res. 2023;10(2):44\u201352. https:\/\/doi.org\/10.36469\/001c.87538.","journal-title":"J Health Econ Outcomes Res"},{"key":"750_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S181242","volume":"11","author":"JA Rassen","year":"2019","unstructured":"Rassen JA, Bartels DB, Schneeweiss S, Patrick AR, Murk W. Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases. Clin Epidemiol. 2019;11:1\u201315.","journal-title":"Clin Epidemiol"},{"key":"750_CR19","unstructured":"Race and ethnicity of the national Medicaid and CHIP population in 2020. https:\/\/www.medicaid.gov\/medicaid\/data-and-systems\/downloads\/macbis\/2020-race-etncity-data-brf.pdf. Accessed Nov 2024"},{"key":"750_CR20","unstructured":"Kaiser\u00a0Family Foundation. Medicaid efforts to address racial health disparities. https:\/\/www.kff.org\/medicaid\/issue-brief\/medicaid-efforts-to-address-racial-health-disparities\/. Accessed on Nov 2024"},{"issue":"01","key":"750_CR21","doi-asserted-by":"publisher","first-page":"054","DOI":"10.1055\/s-0038-1673354","volume":"32","author":"AS Kulaylat","year":"2019","unstructured":"Kulaylat AS, Schaefer EW, Messaris E, Hollenbeak CS. Truven health analytics MarketScan databases for clinical research in colon and rectal surgery. Clin Colon Rectal Surg. 2019;32(01):054\u201360.","journal-title":"Clin Colon Rectal Surg"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00750-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:57:54Z","timestamp":1747648674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00750-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00750-w","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jiachen Zhou, Anna Kuba, Sigrid Nilius, Tha\u00efs Taranc\u00f3n and Frank Tennigkeit are employees and shareholders of UCB. Olga Pilipczuk is an employee of UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The MarketScan\n                      \u00ae\n                      databases used in this study contain fully de-identified\/anonymized data and are fully compliant with the Health Insurance Portability and Accountability Act (HIPAA); therefore, this study was exempt from institutional review board approval and patient consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}